Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zura Bio Limited - Class A Ordinary shares
(NQ:
ZURA
)
4.610
-0.220 (-4.55%)
Streaming Delayed Price
Updated: 3:11 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
304,366
Open
4.710
Bid (Size)
4.610 (300)
Ask (Size)
4.630 (700)
Prev. Close
4.830
Today's Range
4.570 - 4.770
52wk Range
0.9800 - 7.440
Shares Outstanding
62,064,270
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 14, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer
May 13, 2026
From
Zura Bio Limited
Via
Business Wire
Performance
YTD
-16.9%
-16.9%
1 Month
-19.4%
-19.4%
3 Month
-25.8%
-25.8%
6 Month
+10.3%
+10.3%
1 Year
+294.0%
+294.0%
More News
Read More
ZURA BIO LTD (NASDAQ:ZURA) Q1 2026: Cash Runway Extended Through 2028 as Phase 2 Trials Advance
↗
May 07, 2026
Via
Chartmill
Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates
May 07, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 04, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates
March 19, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress
March 05, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio to Participate in Upcoming Investor Conferences
March 02, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
February 27, 2026
From
Zura Bio Limited
Via
Business Wire
Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million
↗
February 25, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges
↗
February 25, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst
↗
February 25, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
February 25, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
February 24, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors
February 23, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit
February 04, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
January 21, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio Reports Business Updates and Outlook for 2026
January 12, 2026
From
Zura Bio Limited
Via
Business Wire
Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates
November 13, 2025
From
Zura Bio Limited
Via
Business Wire
Unusual volume stocks are being observed in Wednesday's session.
↗
October 01, 2025
Via
Chartmill
Here are the top movers in Tuesday's session.
↗
September 30, 2025
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
September 30, 2025
Via
Benzinga
These stocks are moving in today's session
↗
September 30, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 29, 2025
Via
Benzinga
Top stock movements in today's session.
↗
September 29, 2025
Via
Chartmill
Frequently Asked Questions
Is Zura Bio Limited - Class A Ordinary shares publicly traded?
Yes, Zura Bio Limited - Class A Ordinary shares is publicly traded.
What exchange does Zura Bio Limited - Class A Ordinary shares trade on?
Zura Bio Limited - Class A Ordinary shares trades on the Nasdaq Stock Market
What is the ticker symbol for Zura Bio Limited - Class A Ordinary shares?
The ticker symbol for Zura Bio Limited - Class A Ordinary shares is ZURA on the Nasdaq Stock Market
What is the current price of Zura Bio Limited - Class A Ordinary shares?
The current price of Zura Bio Limited - Class A Ordinary shares is 4.610
When was Zura Bio Limited - Class A Ordinary shares last traded?
The last trade of Zura Bio Limited - Class A Ordinary shares was at 05/15/26 03:11 PM ET
What is the market capitalization of Zura Bio Limited - Class A Ordinary shares?
The market capitalization of Zura Bio Limited - Class A Ordinary shares is 286.12M
How many shares of Zura Bio Limited - Class A Ordinary shares are outstanding?
Zura Bio Limited - Class A Ordinary shares has 286M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
